A 75% insulin lispro/25% NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes

Paris Roach, J. Woodworth, U. Gudat, B. Cerimele, F. Diebler, M. Pein, M. Dreyer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims: To compare a new insulin formulation, high mix (HM) [75% lispro (LP) and 25% neutral protamine lispro (NPL)], to regular human insulin (HR) and LP with respect to glucose response and pharmacokinetics following a test meal in patients with Type 1 diabetes. Methods: After fasting overnight, patients received an intravenous insulin infusion to standardize blood glucose (BG) to 7.5 mmol/l (135 mg/dl). In a randomised, three-way crossover study, HR was injected 30 min before, and LP or HM was injected immediately before the test meal on three separate occasions. For each patient, LP and HR were administered at identical doses; the HM dose was one and one third times that of HR and LP to maintain the same dose of short or rapid-acting insulin. The insulin infusion was stopped 15 min after the insulin injection. Free insulin and BG concentrations were measured frequently for 7 h following the test meal. Results: HM and LP resulted in better glycaemic control than HR during the observation period. BG concentrations during the first 4-5 h did not differ between HM and LP. However, HM exhibited prolonged insulin activity relative to LP beyond 5 h, extending the duration of action by approximately 1 h, and resulting in lower overall BG concentrations when the 0-6- and 0-7-h intervals were considered. Conclusions: Compared with LP, HM provided similar glycaemic control for up to 5 h and superior glycaemic control from 5 to 7 h following a standard test meal.

Original languageEnglish
Pages (from-to)946-952
Number of pages7
JournalDiabetic Medicine
Volume20
Issue number11
DOIs
StatePublished - Nov 2003

Fingerprint

Insulin Lispro
Type 1 Diabetes Mellitus
Insulin
Meals
Blood Glucose
Short-Acting Insulin
neutral protamine lispro
Intravenous Infusions
Cross-Over Studies
Fasting
Pharmacokinetics
Observation

Keywords

  • Humalog
  • Insulin analogues
  • Insulin lispro
  • Insulin lispro high mix
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

A 75% insulin lispro/25% NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes. / Roach, Paris; Woodworth, J.; Gudat, U.; Cerimele, B.; Diebler, F.; Pein, M.; Dreyer, M.

In: Diabetic Medicine, Vol. 20, No. 11, 11.2003, p. 946-952.

Research output: Contribution to journalArticle

Roach, Paris ; Woodworth, J. ; Gudat, U. ; Cerimele, B. ; Diebler, F. ; Pein, M. ; Dreyer, M. / A 75% insulin lispro/25% NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes. In: Diabetic Medicine. 2003 ; Vol. 20, No. 11. pp. 946-952.
@article{f6d61c921f484d5d93c44781a7a5bc91,
title = "A 75{\%} insulin lispro/25{\%} NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes",
abstract = "Aims: To compare a new insulin formulation, high mix (HM) [75{\%} lispro (LP) and 25{\%} neutral protamine lispro (NPL)], to regular human insulin (HR) and LP with respect to glucose response and pharmacokinetics following a test meal in patients with Type 1 diabetes. Methods: After fasting overnight, patients received an intravenous insulin infusion to standardize blood glucose (BG) to 7.5 mmol/l (135 mg/dl). In a randomised, three-way crossover study, HR was injected 30 min before, and LP or HM was injected immediately before the test meal on three separate occasions. For each patient, LP and HR were administered at identical doses; the HM dose was one and one third times that of HR and LP to maintain the same dose of short or rapid-acting insulin. The insulin infusion was stopped 15 min after the insulin injection. Free insulin and BG concentrations were measured frequently for 7 h following the test meal. Results: HM and LP resulted in better glycaemic control than HR during the observation period. BG concentrations during the first 4-5 h did not differ between HM and LP. However, HM exhibited prolonged insulin activity relative to LP beyond 5 h, extending the duration of action by approximately 1 h, and resulting in lower overall BG concentrations when the 0-6- and 0-7-h intervals were considered. Conclusions: Compared with LP, HM provided similar glycaemic control for up to 5 h and superior glycaemic control from 5 to 7 h following a standard test meal.",
keywords = "Humalog, Insulin analogues, Insulin lispro, Insulin lispro high mix, Type 1 diabetes",
author = "Paris Roach and J. Woodworth and U. Gudat and B. Cerimele and F. Diebler and M. Pein and M. Dreyer",
year = "2003",
month = "11",
doi = "10.1046/j.1464-5491.2003.01100.x",
language = "English",
volume = "20",
pages = "946--952",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - A 75% insulin lispro/25% NPL mixture provides a longer duration of insulin activity compared with insulin lispro alone in patients with Type 1 diabetes

AU - Roach, Paris

AU - Woodworth, J.

AU - Gudat, U.

AU - Cerimele, B.

AU - Diebler, F.

AU - Pein, M.

AU - Dreyer, M.

PY - 2003/11

Y1 - 2003/11

N2 - Aims: To compare a new insulin formulation, high mix (HM) [75% lispro (LP) and 25% neutral protamine lispro (NPL)], to regular human insulin (HR) and LP with respect to glucose response and pharmacokinetics following a test meal in patients with Type 1 diabetes. Methods: After fasting overnight, patients received an intravenous insulin infusion to standardize blood glucose (BG) to 7.5 mmol/l (135 mg/dl). In a randomised, three-way crossover study, HR was injected 30 min before, and LP or HM was injected immediately before the test meal on three separate occasions. For each patient, LP and HR were administered at identical doses; the HM dose was one and one third times that of HR and LP to maintain the same dose of short or rapid-acting insulin. The insulin infusion was stopped 15 min after the insulin injection. Free insulin and BG concentrations were measured frequently for 7 h following the test meal. Results: HM and LP resulted in better glycaemic control than HR during the observation period. BG concentrations during the first 4-5 h did not differ between HM and LP. However, HM exhibited prolonged insulin activity relative to LP beyond 5 h, extending the duration of action by approximately 1 h, and resulting in lower overall BG concentrations when the 0-6- and 0-7-h intervals were considered. Conclusions: Compared with LP, HM provided similar glycaemic control for up to 5 h and superior glycaemic control from 5 to 7 h following a standard test meal.

AB - Aims: To compare a new insulin formulation, high mix (HM) [75% lispro (LP) and 25% neutral protamine lispro (NPL)], to regular human insulin (HR) and LP with respect to glucose response and pharmacokinetics following a test meal in patients with Type 1 diabetes. Methods: After fasting overnight, patients received an intravenous insulin infusion to standardize blood glucose (BG) to 7.5 mmol/l (135 mg/dl). In a randomised, three-way crossover study, HR was injected 30 min before, and LP or HM was injected immediately before the test meal on three separate occasions. For each patient, LP and HR were administered at identical doses; the HM dose was one and one third times that of HR and LP to maintain the same dose of short or rapid-acting insulin. The insulin infusion was stopped 15 min after the insulin injection. Free insulin and BG concentrations were measured frequently for 7 h following the test meal. Results: HM and LP resulted in better glycaemic control than HR during the observation period. BG concentrations during the first 4-5 h did not differ between HM and LP. However, HM exhibited prolonged insulin activity relative to LP beyond 5 h, extending the duration of action by approximately 1 h, and resulting in lower overall BG concentrations when the 0-6- and 0-7-h intervals were considered. Conclusions: Compared with LP, HM provided similar glycaemic control for up to 5 h and superior glycaemic control from 5 to 7 h following a standard test meal.

KW - Humalog

KW - Insulin analogues

KW - Insulin lispro

KW - Insulin lispro high mix

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=1542498654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542498654&partnerID=8YFLogxK

U2 - 10.1046/j.1464-5491.2003.01100.x

DO - 10.1046/j.1464-5491.2003.01100.x

M3 - Article

VL - 20

SP - 946

EP - 952

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 11

ER -